Oct 8, 2020 | News, Regulatory
A United Arab Emirates company, Group42 or G42, is nearing the end of phase 3 clinical trials for a Chinese COVID-19 vaccine. They are hoping to start producing in the masses next year. This potential vaccine was a product of the partnership between G42, an Abu-Dhabi... 
Oct 5, 2020 | News, Regulatory
Nvidia, a chip industry giant from the U.S., announced today (10/5) that they will be building a supercomputer called Cambridge-1 which will channel artificial intelligence technologies to help researchers find solutions to urgent medical challenges such as COVID-19.... 
Aug 26, 2020 | News, Regulatory
RenalytixAI, an in vitro diagnostics that uses artificial intelligence, has filed a submission to the FDA to clear KidneyIntelx. KidneyIntelx is designed to optimize clinical management and patient outcomes of kidney disease research as well as reduce costs and... 
Jan 31, 2020 | Innovation
An overwhelming surge in the deployment of artificial intelligence and natural language processing tools to understand and control the spread of the latest coronavirus (2019-nCov) has given those watching from the Health Sciences field good cause to be optimistic... 
Apr 16, 2018 | Machine Translation
As the demand for quality affordable translations is ever increasing, the technology to deliver better and faster results is continually being improved upon. Companies are moving beyond traditional translation memory and terminology management systems to find new ways...
